Page last updated: 2024-09-04

ezetimibe and s 8932

ezetimibe has been researched along with s 8932 in 1 studies

Compound Research Comparison

Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010)
(ezetimibe)
Studies
(s 8932)
Trials
(s 8932)
Recent Studies (post-2010) (s 8932)
2,4845631,4651,246521,207

Protein Interaction Comparison

ProteinTaxonomyezetimibe (IC50)s 8932 (IC50)
NS5 Zika virus1.36
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 23.525

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bašić-Jukić, N; Sabljić, Z1

Other Studies

1 other study(ies) available for ezetimibe and s 8932

ArticleYear
Toxic myopathy and liver damage caused by concomitant therapy with remdesivir, atorvastatin, ezetimibe, and tacrolimus in a renal transplant patient with recently treated SARS-CoV-2 induced pneumonia: A case report.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2022, Volume: 26, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Atorvastatin; COVID-19 Drug Treatment; Ezetimibe; Humans; Kidney Transplantation; Liver; Myotoxicity; Pneumonia; SARS-CoV-2; Tacrolimus

2022